Sebastian Szmit Shares Patients’ Perspectives on Decision‑Making for Antithrombotic Therapy in Advanced Cancer
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared an insightful post on LinkedIn:
”Patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer!
The next paper published by our SERENITY Consortium:
Elin Baddeley, Carme Font, Isabelle Mahé, Simon Mooijaart, Anette Arbjerg Højen, Simon Noble, Erik Klok.
International Cardio-Oncology Society
The Multinational Association of Supportive Care in Cancer (MASCC)”
Read the full article here.
Article: “Who am I to say that I’m not going to take it”: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer
Authors: Elin Baddeleya, Carme Font, Isabelle Mahé, Michelle Edwards, Stephanie Sivell, Kate J. Liffordd,Victoria Mailen Arfuch, Nuri Coma-Auli, Mette Søgaard, Helle Enggaard, Hélène Helfer, Nassima Si Mohammed, Kathy Seddona, Mark Pearson, Simone P. Mooijaart, Sebastian Szmit, F.A. Klok, Simon Noble, Anette Arbjerg Højen
Stay updated with Hemostasis Today.
-
Apr 13, 2026, 17:41Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
-
Apr 13, 2026, 17:39Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
-
Apr 13, 2026, 17:38Tareq Abadl: A Blood Transfusion Can Cause a Delayed Platelet Crash
-
Apr 13, 2026, 13:33Tetsumei Urano: Join for the ISTH Educational Programs at APSTH 2026 in Japan
-
Apr 13, 2026, 13:26Salih Ehsan: Neutrophil Behavior Across Pregnancy and Infection Assessment
-
Apr 13, 2026, 13:20Denis Oduor: Autologous Blood Transfusion – A Significant Moment in Patient Care and Choice
-
Apr 13, 2026, 13:13Tareq Abadl: How the Immune System Turns Against the Body in Autoimmune Diseases
-
Apr 13, 2026, 13:13Yousra Tera: Celebrating a Lasting Impact on Future Generations
-
Apr 13, 2026, 13:07Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study